MORE►
algorithm
Lantern Pharma CEO Panna Sharma [Courtesy: Lantern Pharma]
Busting the Brain’s Firewall: How Lantern Pharma’s Algorithms Can Predict a Drug’s Ability to Reach the Brain
by Lance Murray | May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
by Kevin Cummings |
Jun 22, 2022
AlgoPear, a subscription-based algorithmic stock trading platform, has onboarded more than 4,000 users and grown its monthly recurring revenue with a team of 15, according to co-founder and CEO Ronnie Green.
Green says the startup is seeing the "hypergrowth that any founder or any investor would love to see right now."
Green says the startup is seeing the "hypergrowth that any founder or any investor would love to see right now."
MORE►
by Lance Murray |
Dec 13, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also find out about how scientists at the University of North Texas Health Science Center are studying the benefits of older women with hypertension taking warm leg baths.
MORE►
by Lance Murray |
Dec 12, 2019
The Genomic Profiling Similarity Score uses over 6,500 mathematical models in a machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database.
MORE►
